Image Technology Laboratories says it raised $1.3 million through an initial public offering completed in mid-January. The PACS company is now trading publicly on the OTC Bulletin Board under the symbols IMTL, IMTLW, and IMTLZ. ITL claims to
Image Technology Laboratories says it raised $1.3 million through an initial public offering completed in mid-January. The PACS company is now trading publicly on the OTC Bulletin Board under the symbols IMTL, IMTLW, and IMTLZ. ITL claims to be the only publicly traded company specializing exclusively in PACS.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.